Skip to main content
Top

Drugs

Issue 10/2021

Content (13 Articles)

Current Status of Clinical Trials on Tau Immunotherapies

Changyi Ji, Einar M. Sigurdsson

Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting

Zhaosheng Jin, Neil Daksla, Tong J. Gan

Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents

Sho Hasegawa, Masato Yoneda, Yusuke Kurita, Asako Nogami, Yasushi Honda, Kunihiro Hosono, Atsushi Nakajima

Remimazolam: A Review in Procedural Sedation

Arnold Lee, Matt Shirley

Dostarlimab: First Approval

  • NSCLC
  • AdisInsight Report

Anthony Markham

Fuzuloparib: First Approval

Arnold Lee

Loncastuximab Tesirine: First Approval

Arnold Lee

Correction to: Lazertinib: First Approval

  • Open Access
  • Correction

Sohita Dhillon

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images